T1	Participants 84 116	patients with malignant neoplasm
T2	Participants 207 239	patients with malignant neoplasm
T3	Participants 275 286	51 patients
T4	Participants 383 418	48 healthy adults were also studied
T5	Participants 997 1018	patients with cancer.
